Update on the treatment of narcolepsy: clinical efficacy of pitolisant - Wikidata - awgldk - TriplyDB

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

http://www.wikidata.org/entity/Q33631290

about

Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Off-label Sodium Oxybate in Childhood Narcolepsy: A Comprehensive Report.

P2860

Q50044639-F9357A96-2C2F-4CD3-A4E5-71AA15DC08C1 Q55350248-A1E04365-3097-48E1-8122-6873A29EC6E6

P2860

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

http://www.wikidata.org/entity/Q33631290

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@ast

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@en

type

label

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@ast

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@en

prefLabel

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@ast

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@en

P1433

Q33631290-6864499A-8A51-44B6-A0B3-9D0F9E1BF615

P1476

Q33631290-0C00C194-A738-4482-B2A9-95CA43430300

P2860

Q33631290-10882503-E3C7-45D9-A73A-6C4F15FD3967

Q33631290-150C119C-0F4E-4697-927B-A05A379BFAB9

Q33631290-15CA4B80-D79A-4E24-8E26-A5000DDE2019

Q33631290-1CC64196-1FED-44CA-9D46-E157DBDE7C6E

Q33631290-2D8DC7C2-4A4E-4125-B74C-F51EC7D85F21

Q33631290-47856F94-AD6F-4F2F-93BD-C07B7FDA4722

Q33631290-48081511-46E9-4843-8A15-740E5DA800FA

Q33631290-52A456D3-4B8F-44CF-B063-5F692031CA1E

Q33631290-564C85C5-BBAB-411F-8E22-896F2D7772B8

Q33631290-7D6258B9-DCE3-480C-8A3D-02BF8FA3222C

P304

Q33631290-DBEBA35D-F8B1-418A-97C8-43385C6E3845

P31

Q33631290-5CF867D2-A381-438F-9BF6-0992B2451C30

P356

Q33631290-48F27EEF-2D53-4824-8EC1-6F7EAAB3AF04

P478

Q33631290-46F9CE84-5F90-48BB-8D2D-72380EB387A9

P50

Q33631290-E8CF4662-92BE-4836-B155-0384EF3BC2FD

P577

Q33631290-3C3E0E36-94B0-4A84-B2F1-C41A6CB6D116

P698

Q33631290-32F2A633-7EED-42A8-B844-8CB93BC78693

P921

Q33631290-4668C7BA-74B3-4A32-A18E-C0C44383E647

P932

Q33631290-A56A0161-6BCF-4B54-84FA-27AE999C8ACE

P356

P1433

Nature and Science of Sleep

P1476

Update on the treatment of narcolepsy: clinical efficacy of pitolisant

@en

P2860

The Safety of Adjuvanted Vaccines Revisited: Vaccine-Induced Narcolepsy

Treatment paradigms for cataplexy in narcolepsy: past, present, and future

The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review

The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders

An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.

Histamine in the nervous system.

The histamine H3 receptor as a therapeutic drug target for CNS disorders.

Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test

The epidemiology of narcolepsy.

Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence

P304

127-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NSS.S103462

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28490912

http://www.w3.org/2001/XMLSchema#string

P921

P932

5414617

http://www.w3.org/2001/XMLSchema#string